CXCL9 and neoplasm: NPSur-C9AP is demonstrated to specifically co-express CXCL9 and αPD-L1 in different tumor cells, which proves the expandability of tumor-specific gene nanomedicine to increase T-cell infiltration and activation for enhanced immunotherapy.